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term linezolid treatment.
Methods: A retrospective analysis was conducted to calculate the cumula-
tive amount of linezolid administered to an elderly patient with pneumonia
during prolonged therapy with linezolid. Three sequential isolates were
identified, its minimum inhibitory concentration (MIC), homology and drug
resistant related genes (cfr, 23S rRNA) were investigated.
Results: One linezolid-resistant strain of methicillin-resistant Staphylo-
coccus aureus (MRSA) was isolated from sputum of the patient at Xijing Hos-
pital. The MIC of linezolid had increased from 1.5 mg/ml of initial strain 083
in March 2012 to subsequent 4.0 mg/ml of strain 158 in November 2012 and
16.0 mg/ml of strain 231 in March 2013 respectively. The increasing MIC
values to linezolid were directly correlated with the cumulative amount of
linezolid 118.8 g administered over 99 days. Strain 158 had heterogeneous
resistance to linezolid. Molecular typing showed that three MRSA strains
belonged to MLST ST-239 (spa t-030) with 98.8% homology. Cfr mutation
was not detected but 23S rRNA mutation G2603T was confirmed in strains
158 and 231.
Conclusions: This is the first case of linezolid-resistant MRSA isolated in
China. The long-term use of linezolid for the treatment of MRSA infection
was associated with a 23S rRNA G2603T mutation, which mediates heteroge-
neous resistance to linezolid. And the strain with heterogeneous resistance
might progress to a high-level linezolid-resistant strain when re-exposed to
linezolid.
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Background: Methicillin-resistant Staphylococcus aureus (MRSA) is the
most frequent organism that causes severe healthcare- and community-
associated infections. Association of molecular types and antimicrobial
susceptibility test (AST) profiles has been reported. The goal is to corre-
late various molecular types with AST profiles of MRSA isolates from
Taiwan.
Materials and Methods: MRSA from sterile sites were collected during 5
years from 22 hospitals (Tigecycline In-vitro Surveillance in Taiwan e
TIST 2006e2010) and AST including seventeen antibiotic regimens and
inducible macrolide-lincosamide- streptogramin B (MLSBi) phenotype
were determined by Vitek-II automated system. Molecular types including
SCCmec, spa, and dru were determined by PCR and nucleotide
sequencing. Multidrug resistance (MDR) was defined an isolate with resis-
tance to more than or equal to three non-b-lactam antibiotics. Correlation
with molecular types with antibiotic resistance was determined by
Fisher’s exact test.
Results: Totally 670 mecA+ MRSA were collected, among which most were
from blood (627, 93.6%). The susceptibility rates determined by Vitek-II
were as followed: linezolid and teicoplanin (100%), vancomycin (99.9%),
tigecycline (99.7%), daptomycin (95.1%), fusidic acid (85.5%), rifampicin
(68.7%), trimethoprim (53.7%), moxifloxacin (36%), tetracycline (34.2%),
and less than 10% for cefoxitin, cefazolin, penicillin, oxacillin, erythro-
mycin, clindamycin, and ampicillin/sulbactam. MRSA with MDR (542,
80.9%) was associated with molecularly HA-MRSA (e.g., SCCmecII&III;
spa t002&t037; agr group II; dru4, 12, and 14). (p from < 0.001 to <
0.01). MLSBi (57, 8.5%) correlated with molecular types of SCCmecIII&V,
spa t3525, and agr group III (p < 0.01). The compound annual growth
rate of susceptibility from 2006 to 2010 ranged from -2% of fusidic acid
to 13% of clindamycin and 17% of erythromycin, respectively.
Conclusions: MRSA from Taiwan had varied AST profiles and some with
increasing susceptibility within 5 years. Strains with particular molecularphenotypes had corresponding AST profiles that were distinct from those
of endemic MRSA clones reported.
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DISTRIBUTION AND DRUG RESISTANCE OF PATHOGENS CULTURED FROM
63229 BLOOD SPECIMENS
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Purpose: Dynamic Monitoring and Analysis in our hospital from 2007 to 2013
clinical testing of blood culture samples isolated pathogen distribution and
drug resistance changes, the rational use of antimicrobial drugs for clinical
laboratory evidence.
Methods: Using BACTEC automated blood culture system on 63,229 blood
specimens for testing; application of automatic identification of bacteria
bacterial identification analyzer identified to species; bacterial susceptibil-
ity testing by KB method, according to the American Society for Clinical Lab-
oratory Standards Institute requirements standards; pathogen distribution
and antimicrobial susceptibility test results apply WHONET5.6 software for
statistical analysis.
Results: From a clinical inspection of 63,229 blood specimens, the positive
culture 4914, the positive rate of 7.77%, were detected pathogens 2196,
which accounted for 46.08 Enterobacteriaceae (1012/2196), nonfermenters
13.93 (306/2196) ; Staphylococcus 13.70 (301/2196), Enterococcus 8.24
(181/2196); mainly Gram-negative bacteria Escherichia coli, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, The
detection rates were 25.50%, 11.47%, 7.14%, 5.91%. Gram-positive bacteria
to coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus,
grass green hammer main separation rates were 10.40%, 7.42%,
6.87,3.91%. Fungal 7.05 (155/2196), the separation rate of the first two of
Candida albicans and Candida tropicalis, the detection rates were 2.18%,
2.00%; brucellosis 1.01 (32/2196), pollution bacteria 4.01 (88/2196), produc-
ing ESBLs of Escherichia coli and Klebsiella pneumoniae separation rates
were 75.53%, 55.51%; methicillin-resistant Staphylococcus aureus (MRSA)
isolation rate was 62.6%, not seized the resistance to vancomycin, line-
zolid-resistant Staphylococcus aureus.
Conclusions: Bloodstream infection pathogen distribution as Escherichia
coli, Klebsiella pneumoniae, coagulase-negative staphylococci, Staphylo-
coccus aureus, Enterococcus, Acinetobacter baumannii, Pseudomonas aeru-
ginosa. Clinical blood culture specimens should be strictly in accordance
with the norms adopted send execution to avoid pollution and improve the
quality inspection.
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Background: Infections with carbapenem-resistant Klebsiella pneumoniae
(CRKP) are emerging causes of morbidity and mortality at institutions world-
wide. In addition, the efficacy of cefepime for such infections is
controversial.
Methods: A retrospective study of monomicrobial bloodstream infections
(BSIs) caused by Klebsiella pneumoniae resistant to one of ertapenem, imi-
penem or meropenem, at a medical center between 2008 and 2013, was con-
ducted. The 30-day crude mortality was the primary end point.
